J Koch-Weser. Show Affiliations »
Abstract
Mesh: See more » Antibodies, Antinuclear/analysisArthritis, Rheumatoid/chemically inducedBlood Pressure/drug effectsCardiac Output/drug effectsChronic DiseaseDrug EvaluationDrug SynergismHumansHydralazine/administration & dosageHydralazine/adverse effectsHydralazine/metabolismHydralazine/pharmacologyHydralazine/therapeutic useHypertension/drug therapyLupus Erythematosus, Systemic/chemically inducedPropranolol/therapeutic useVascular Resistance/drug effects
Substances: See more » Antibodies, AntinuclearHydralazinePropranolol
Year: 1976 PMID: 778618 DOI: 10.1056/NEJM197608052950606
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245